Strategies to optimize siRNA delivery to hepatocellular carcinoma cells-Reference-Cited by-同舟云学术

Strategies to optimize siRNA delivery to hepatocellular carcinoma cells

Published:2017-02-17 Issue:6 Volume:14 Page:797-810
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Scarabel Lucia¹,Perrone Francesca²,Garziera Marica¹,Farra Rossella³,Grassi Mario³,Musiani Francesco⁴,Russo Spena Concetta¹,Salis Barbara¹,De Stefano Lucia¹,Toffoli Giuseppe¹,Rizzolio Flavio¹,Tonon Federica³,Abrami Michela²,Chiarappa Gianluca³,Pozzato Gabriele⁵,Forte Giancarlo⁶,Grassi Gabriele²⁵,Dapas Barbara²

Affiliation:

1. Experimental and Clinical Pharmacology Unit, C.R.O. National Cancer Institute, Aviano, Italy

2. Department of Life Sciences, Cattinara University Hospital, University of Trieste, Trieste, Italy

3. Department of Engineering and Architecture, University of Trieste, Trieste, Italy

4. Laboratory of Bioinorganic Chemistry, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy

5. Department of ‘Scienze Mediche, Chirurgiche e della Salute’, Cattinara University Hospital, University of Trieste, Trieste, Italy

6. Center for Translational Medicine, International Clinical Research Center, St. Anne’s University Hospital, Brno, Czech Republic

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2017.1292247

Reference95 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Sustained complete remission of advanced hepatocellular carcinoma with sorafenib therapy

3. Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials

4. CRISPR-Cas9 System as a Versatile Tool for Genome Engineering in Human Cells

5. Aptamers as Targeting Delivery Devices or Anti-cancer Drugs for Fighting Tumors

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biotinylated polyaminoacid-based nanoparticles for the targeted delivery of lenvatinib towards hepatocarcinoma;International Journal of Pharmaceutics;2024-09

2. Liposomal nanocarriers containing siRNA as small molecule-based drugs to overcome cancer drug resistance;Nanomedicine;2023-11-15

3. Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma;Pharmaceutics;2023-08-14

4. The Role of Small Interfering RNAs in Hepatocellular Carcinoma;Journal of Gastrointestinal Cancer;2023-07-11

5. Targeting Non-Coding RNAs for the Development of Novel Hepatocellular Carcinoma Therapeutic Approaches;Pharmaceutics;2023-04-15